Omada Health, INC

Omada Health announced robust Q2 2026 financial results, including 43% year-over-year revenue growth and a shift to net income, alongside a planned CEO transition.

Omada Health, Inc. held its 2026 Annual Meeting of Stockholders, where shareholders elected directors Sean Duffy and Trevor Fetter and ratified the appointment of Deloitte & Touche LLP as its independent auditor.

Omada Health announced robust fourth-quarter and full-year 2025 results, featuring significant revenue and member growth, alongside achieving positive net income in Q4 and positive Adjusted EBITDA for the full year.

Omada Health announced preliminary, unaudited revenue for Q4 and full year 2025, showing significant growth and increased member count, ahead of its J.P. Morgan Healthcare Conference presentation.

Omada Health reports strong third-quarter 2025 results with significant revenue growth, reduced net loss, positive Adjusted EBITDA, and a new GLP-1 offering.

Omada Health reported strong second quarter 2025 financial results, with revenue increasing 49% year-over-year and significant progress towards profitability.

Omada Health reported a 43% increase in total revenue for the second quarter of 2026 compared to the same period in 2025, driven by member growth and program expansion, alongside improved gross margins.

Omada Health reports strong first-quarter revenue growth of 42% to $78 million, significantly reducing its net loss to $3 million, driven by a 51% increase in total members.

Omada Health reports strong Q3 2025 revenue growth of 49% to $68.0 million, significantly reducing net loss to $3.2 million, driven by increased member enrollment and operational efficiencies.

Omada Health reported significant revenue and member growth in Q2 2025, alongside a successful IPO that substantially improved its cash position and enabled full debt repayment.

Omada Health, a virtual care provider, announced a significant increase in revenue and a substantial reduction in net losses for the fiscal year ended December 31, 2025, driven by member growth and operational efficiencies.

Wei-Li Shao, President of Omada Health, Inc., sold 8,866 shares of common stock on August 12, 2026 for $25.02 per share.

Steven L. Cook, Chief Financial Officer of Omada Health, Inc., sold 16,842 shares of common stock on August 10, 2026.

Craig Gracey, Chief Accounting Officer of Omada Health, Inc., sold 1,042 shares of common stock on August 10, 2026 for $25.00 per share.

Sean P. Duffy, Chief Executive Officer and a Director of Omada Health, Inc., sold 21,570 shares of common stock on August 7, 2026.

Sean P. Duffy, Chief Executive Officer and a Director of Omada Health, Inc., sold 12,944 shares of common stock on August 3, 2026 for $20.40 per share.

Jeryl L Hilleman, a Director of Omada Health, Inc., received 1,435 shares of common stock on July 5, 2026.

Omada Health, Inc. has filed an S-1/A registration statement for its initial public offering of 7,500,000 shares of common stock, with an anticipated price range of $18.00 to $20.00 per share, aiming to raise approximately $133.2 million for general corporate purposes and potential acquisitions.

Omada Health, a leading virtual care provider, has filed an S-1 registration statement for an initial public offering, seeking to expand its reach in the growing market for chronic condition management.

American Century Investment Management, Inc. and its affiliates have reported beneficial ownership of 6.2% of Omada Health, Inc. common stock as of June 30, 2026.

Divisadero Street Capital Management, LP and affiliated entities have reported beneficial ownership of 9.9% of Omada Health, Inc. common stock as of March 31, 2026.

FMR LLC and Abigail P. Johnson have reported beneficial ownership of 5.6% of Omada Health Inc.'s common stock as of March 31, 2026.

Divisadero Street Capital Management, LP and affiliated entities have reported beneficial ownership of 8.7% of Omada Health, Inc.'s common stock.

FMR LLC and Abigail P. Johnson have reported a beneficial ownership of 8.5% of Omada Health Inc.'s common stock, totaling 4,911,500 shares.

U.S. Venture Partners X and its affiliates have reported an 8.2% beneficial ownership stake in Omada Health, Inc., signaling a significant passive investment.